Hyperthyroidism
Red Flags — act before continuing history
| Red flag | Why dangerous | Action |
|---|---|---|
| Fever >38.5°C + HR >140 bpm + agitation / confusion / vomiting (Burch-Wartofsky score ≥45) | Thyroid storm — 10–25% mortality even with treatment. Precipitated by infection, surgery, iodine load, or sudden cessation of antithyroid drugs. Requires ICU-level multi-drug management. | 999 immediately |
| New AF with haemodynamic compromise (hypotension, chest pain, syncope, breathlessness at rest) | Thyrotoxic AF drives high ventricular rate → rapid haemodynamic deterioration. Thromboembolic risk 2–3× elevated even with thyrotoxicosis as sole risk factor. | 999 immediately |
| Acute flaccid paralysis / profound proximal weakness + hypokalaemia in East Asian male | Thyrotoxic periodic paralysis — hypokalaemia drives K⁺ intracellularly. Can cause respiratory failure. Requires urgent IV K⁺ and beta-blockade. | 999 immediately |
| Proptosis + corneal exposure / reduced visual acuity / colour vision loss | Sight-threatening Graves' ophthalmopathy — corneal ulceration and optic nerve compression can cause permanent blindness if not treated within hours to days. | Same-day ophthalmology |
| Severe vomiting in pregnancy + suppressed TSH + gestational age <20 weeks | Gestational hyperthyroidism (HCG-mediated) or unmasked Graves'. Untreated = miscarriage, pre-eclampsia, fetal growth restriction, neonatal hyperthyroidism. | Same-day obstetric review |
| Chest pain + palpitations + sweating in known hyperthyroid patient | ACS triggered by thyrotoxicosis-induced increased myocardial oxygen demand and coronary vasospasm. Thyrotoxic cardiomyopathy = reversible dilated cardiomyopathy. | 999 — rule out ACS |
Safeguarding Considerations — Consider in Every Consultation
🏠 Domestic Abuse / Intimate Partner Violence
- Anxiety, weight loss, and tremor may represent consequences of chronic fear — not just thyroid pathology; consider both simultaneously
- Partner insisting on being present during examination = controlling behaviour signal; see patient alone
- Patient reluctant to commit to follow-up — consider whether a controlling relationship is preventing healthcare engagement
- Ask sensitively: "Sometimes difficult home situations can affect physical health too — is everything okay at home for you?"
👴 Older Adults / Carer-related Concern
- Apathetic thyrotoxicosis in the elderly — weight loss, AF, and cognitive decline misattributed to 'normal ageing' — a dangerous missed diagnosis
- Who is administering carbimazole? Is medication adherence being monitored or deliberately disrupted by a carer?
- Financial exploitation: is the patient being denied healthcare or pressured to cancel appointments?
- Cognitive testing: hyperthyroidism can cause reversible dementia-like symptoms — document and repeat post-treatment
🧒 Children in the Household
- Factitious disorder imposed on another (FDIA): levothyroxine is small, tasteless, and readily available — exogenous T4 causes suppressed TSH and elevated FT4 identical to endogenous hyperthyroidism
- Consider FDIA if child presents with recurrent thyrotoxic episodes with negative TRAb and zero radionuclide uptake
- Maternal Graves' with positive TRAb: neonatal surveillance required even if mother is euthyroid post-treatment — TRAb crosses placenta
- Paediatric Graves': significant school performance impact; CAMHS support; involve school with consent
💊 Self-Harm / Medication Misuse Risk
- Levothyroxine misused for weight loss in patients with eating disorders or body dysmorphia — screen for factitious thyrotoxicosis (low thyroglobulin, low uptake scan)
- Carbimazole: patients in crisis may omit the agranulocytosis warning and deliberately take large doses — assess mental health status at every consultation
- Severe thyrotoxicosis-driven anxiety can precipitate psychiatric crisis — screen sensitively for self-harm ideation
- If eating disorder suspected: measure thyroglobulin and thyroid-binding globulin to distinguish exogenous from endogenous thyrotoxicosis
💼 Occupational Stress & Work Pressure
Chronic HPA activation from sustained workplace stress may precipitate or maintain autoimmune thyroid disease by reducing regulatory T-cell tolerance to thyroid antigens. The evidence for stress as a trigger for Graves' onset is moderate but consistent across case-control studies.
"How has your life been in terms of stress or big changes in the months leading up to this? Sometimes significant stress can act as a trigger for the immune system."If high stress identified: NHS Talking Therapies referral; occupational health; phased return-to-work planning. Stress reduction may lower relapse risk after completing antithyroid drug course.
🚬 Smoking Status
Tobacco smoke contains thiocyanate which directly damages orbital fibroblasts and synergises with TRAb to drive Graves' ophthalmopathy. Smokers have 2-fold increased risk of any ophthalmopathy and 8-fold increased risk of severe GO versus non-smokers. Radioiodine in active smokers significantly increases ophthalmopathy risk.
"Are you currently smoking? I'm asking because smoking actually doubles the chance of the thyroid disease affecting your eyes — stopping is one of the most effective things you can do alongside treatment."Offer NRT and smoking cessation referral at every appointment. Radioiodine should be deferred or given with steroid prophylaxis if patient is still smoking.
💑 Reproductive Plans & Fertility
Untreated hyperthyroidism impairs ovulation and is associated with first-trimester miscarriage, pre-term birth, and placental abruption. Carbimazole carries a risk of embryopathy (choanal atresia, aplasia cutis) in weeks 6–10 of organogenesis — PTU is preferred if pregnancy is possible or imminent. TRAb crosses the placenta and can cause neonatal Graves' disease.
"You mentioned wanting another child — that's really important for our planning, because it changes which medication we should start. Can you tell me more about your timing?"If pregnancy possible within months: start PTU not carbimazole; check TRAb; obstetric team liaison; plan fetal surveillance. Contraception essential if radioiodine is being considered — avoid pregnancy for 6 months post-RI.
😴 Sleep Disruption & Insomnia
Thyroid hormone excess reduces slow-wave sleep and increases nocturnal adrenergic tone. Persistent insomnia worsens anxiety, impairs cognitive function, and reduces medication adherence. Benzodiazepines are relatively contraindicated in thyrotoxic agitation. Evening propranolol provides the most practical symptomatic relief.
"How is your sleep? People with an overactive thyroid often struggle to switch off at night — has that been happening for you?"Sleep hygiene advice; low-dose propranolol in the evening; avoid Z-drugs and benzodiazepines. Reassure that sleep improves significantly once euthyroid state is achieved.
⚖️ Body Image & Weight Concerns
Some patients — particularly young women — are distressed by weight gain as treatment returns metabolism to normal. This can lead to deliberate omission of carbimazole to maintain the lower weight. In extreme cases, levothyroxine is self-administered to induce thyrotoxicosis for weight loss (factitious thyrotoxicosis). Anticipatory counselling prevents dangerous non-adherence.
"As your thyroid returns to normal, you may notice your weight returning to where it was before — that's actually a sign that the treatment is working. How do you feel about that?"If eating disorder features: NHS Talking Therapies/CEED referral; dietitian; screen for factitious thyrotoxicosis (very low thyroglobulin, low uptake scan); involve mental health team.
🧠 Pre-existing Mental Health
Anxiety and depression are frequently misdiagnosed as primary psychiatric conditions when the underlying cause is hyperthyroidism. TFTs are mandatory in any new-onset anxiety or mood disorder in women aged 20–50. Conversely, true psychiatric comorbidity can be exacerbated by thyrotoxicosis and improve substantially once euthyroid state is restored.
"Have you ever been diagnosed with anxiety or depression before, or been on medication for your mood? Sometimes what looks like anxiety turns out to be connected to the thyroid, and I want to make sure we're treating the right thing."Review appropriateness of anxiolytics/antidepressants once euthyroid — many can be safely weaned. If psychiatric symptoms persist after TFT normalisation: formal psychological review.
- Asking for TFT results already documented in the case notes
- Starting targeted questions before attempting an open question
- Failing to ask about pregnancy plans before prescribing carbimazole
- Missing the fertility concern entirely when patient mentions wanting a child
- Asking all three ICE questions in rapid succession as a formulaic list
- Moving to management before the patient has had the opportunity to ask their own question
999 or Same-Day Hospital
Call 999 / A&E now- Thyroid stormBurch-Wartofsky ≥45 — fever, HR >140, altered consciousness, vomiting
- Haemodynamically compromised thyrotoxic AFHypotension, syncope, chest pain, severe breathlessness at rest
- Thyrotoxic periodic paralysisAcute flaccid quadriparesis + hypokalaemia — IV K⁺ urgently required
- Acute corneal exposure in Graves' ophthalmopathyCorneal ulceration = imminent permanent sight loss
- Severe gestational hyperthyroidism with haemodynamic instabilityHyperemesis + electrolyte disturbance + haemodynamic compromise in pregnancy
Same-Day GP / Urgent Referral
Days to 2 weeks- New Graves' disease — first presentationStart carbimazole + propranolol today; urgent endocrinology referral within 2 weeks
- Hyperthyroidism confirmed in pregnancySame-day or next-day obstetric liaison — TRAb + PTU in T1
- Stable new-onset thyrotoxic AFAnticoagulation decision; rate control; euthyroid before cardioversion
- Paediatric hyperthyroidismUrgent paediatric endocrinology — different dosing and monitoring protocols
- Agranulocytosis features on carbimazoleSore throat + fever + leucopenia → STOP carbimazole immediately; same-day A&E
Manage in Primary Care
GP practice- Subclinical hyperthyroidism (TSH 0.1–0.4, normal FT4)Monitor; treat only if elderly, osteoporotic, or cardiac risk present
- Known Graves' on established antithyroid therapyRoutine TFT monitoring; medication titration; 4–6 weekly review
- Post-radioiodine monitoringRegular TFTs for hypothyroidism; levothyroxine dose adjustment
- Euthyroid block-and-replace — scheduled reviewTFTs stable; planning cessation at 18 months for remission testing
- Post-thyroidectomy monitoringRoutine TFT review; levothyroxine dose optimisation
- Sending home a patient with thyroid storm features without 999 call
- Deferring all treatment to endocrinology — patient left untreated in interim
- Not asking about pregnancy before triaging to routine (pregnancy = urgent upgrade)
- Classifying new stable thyrotoxic AF as routine — needs anticoagulation assessment same day
- Omitting ophthalmological assessment in suspected Graves' disease
- Not checking pulse rate and rhythm despite history of palpitations
- Offering examination without explaining the clinical reason to the patient
- Performing a full systemic examination — wastes time; targeted exam is correct approach
- Starting carbimazole without baseline FBC — agranulocytosis monitoring compromised
- Not checking pregnancy before initiating antithyroid drug therapy in female of reproductive age
- Prescribing carbimazole in a patient with low uptake (De Quervain's) — ineffective and causes side effects
- Ordering tests without explaining the clinical question each one answers
- Not performing ECG in patient with palpitations or irregular pulse on examination
"Your thyroid gland — which sits at the front of your neck — is a bit like the body's engine throttle. In your case, the throttle is stuck in the 'full on' position, producing far more fuel than your body needs. That's why everything is running too fast — your heart, your metabolism, your nervous system. The most common cause of this is something called Graves' disease — where your own immune system accidentally tells the thyroid to go into overdrive. Think of it as a case of mistaken identity by the immune system. It is not cancer. The reason you feel wired, lose weight despite eating more, and feel hot all the time is because your body is burning through everything at double speed. The good news is that this responds very well to treatment, and most of your symptoms should start improving within the first few weeks."
"I'm convinced I have thyroid cancer — the weight loss is terrifying me."
"I completely understand why weight loss raises that fear, and I want to address it directly: thyroid cancer behaves very differently to this — it usually causes a painless lump in the neck rather than this pattern of symptoms, and it doesn't make your blood levels look like this. What we're seeing in your blood tests is your thyroid producing too much hormone — that's a very different problem, and a very treatable one. We will examine your thyroid carefully, but I want to take that particular worry off the table today."
"I think it's just stress — I've been working incredibly hard and haven't had a break."
"Stress is definitely a contributing factor, and it may even have been the trigger — we know it can affect the immune system in exactly this way. But the blood test result shows the thyroid is producing far more hormone than stress alone can explain — this is a biochemical finding that needs treatment in its own right. The great news is that treating the thyroid will also make you feel much calmer and less anxious — so we'll be helping both problems at once."
Toxic Multinodular Goitre (TMNG)
Multiple autonomous hot nodules. Age >50, endemic goitre areas. Radioiodine or surgery preferred — low remission rate with antithyroid drugs alone.
Toxic Adenoma (Plummer's Disease)
Single autonomous hot nodule — TRAb negative. Radioiodine or surgical excision is curative. Carbimazole only as bridge to definitive treatment.
TSH-Secreting Pituitary Adenoma
Central hyperthyroidism — TSH normal or elevated with high FT4/FT3. Very rare (<1%). MRI pituitary. Neurosurgery + endocrinology joint management.
Thyroid Storm (Thyrotoxic Crisis)
Burch-Wartofsky ≥45 — fever, HR >140, altered consciousness, vomiting, AF. Mortality 10–25%. Requires carbimazole + Lugol's (after carbimazole) + propranolol + steroids + supportive care. 999 immediately.
Severe Graves' Ophthalmopathy — Corneal Exposure
CAS ≥3 + corneal ulceration or optic nerve compression. IV methylprednisolone + same-day ophthalmology. Sight loss is permanent if delayed.
- Using "hyperthyroidism" without explaining it — examiner scores this as jargon
- Not directly addressing the cancer fear if the patient has expressed it
- Moving straight to treatment without naming the working diagnosis
- Diagnosing Graves' in a patient who actually has De Quervain's (different management entirely)
- Waiting for endocrinology before starting carbimazole — patient left undertreated in the interim
- Not explaining what the referral is for or what happens next — generates avoidable anxiety
- Not mentioning definitive treatment options — undermines informed consent
- Offering radioiodine to a patient with active Graves' ophthalmopathy without ophthalmology assessment
Validate — name their expectation
Most patients want either immediate cure or reassurance they won't need lifelong medication. Both are legitimate expectations. Acknowledging the expectation before explaining your plan prevents the patient from feeling dismissed.
"I completely understand why you don't want to be on medication forever — that's a completely reasonable thing to want. And with Graves' disease specifically, that goal is actually achievable for many people. Let me explain how."Explain — share your clinical reasoning
Explain the treatment timeline honestly — including remission probability, relapse risk, and definitive options. Patients who understand the pathway complete the full antithyroid drug course rather than stopping early when they feel better.
"The tablet I want to start today will bring your thyroid hormone down over 4–6 weeks. We then continue for 12–18 months. At that point, roughly half of people achieve a lasting remission. If it comes back, there are permanent treatments — radioiodine or surgery — that genuinely cure it."Negotiate — offer something today
Never leave with nothing agreed. The patient should leave feeling this appointment has been productive and that care has started — reducing the burden of waiting for specialist review.
"What I can do today: start the carbimazole, give you the heart tablet to calm your palpitations, arrange bloods and an ECG, and book you a review in 4–6 weeks to check your levels. You should start feeling better within 2–3 weeks. How does that sound?"Thiocyanate in tobacco smoke stimulates orbital fibroblasts and synergises with TRAb to worsen Graves' ophthalmopathy. Smokers have 2× increased risk of any GO and 8× greater risk of severe GO versus non-smokers. Radioiodine response impaired by ~20% in active smokers.
Offer NRT at every appointment. Refer to NHS Stop Smoking Service. Set a quit date with patient. Varenicline if non-pregnant with no psychiatric CI. Radioiodine should be deferred or given with steroid prophylaxis if patient still smoking.
Excess dietary iodine provides additional substrate for thyroid hormone synthesis and can blunt the response to carbimazole. Iodine-containing supplements (multivitamins, kelp, high-dose iodine drops) should be stopped immediately.
Check all supplements — multivitamins, protein powders, and herbal preparations often contain iodine. Avoid kelp and seaweed products. If CT with contrast is needed, discuss with endocrinologist first — iodine load can transiently worsen thyrotoxicosis.
High-intensity exercise in untreated thyrotoxicosis raises heart rate further and risks arrhythmia. Muscle catabolism from thyrotoxicosis means exercise during active disease provides less benefit and higher risk. Proximal myopathy limits exercise tolerance.
Advise gentle walking, swimming, or yoga until TFTs normalise. Avoid competitive sport, gym training, and heavy lifting until euthyroid. Once euthyroid: return to full activity — exercise rebuilds muscle mass lost during thyrotoxicosis.
Thyroid hormone excess reduces slow-wave sleep and raises nocturnal adrenergic tone. Sleep deprivation amplifies anxiety and cognitive effects — creating a vicious cycle. Evening propranolol reduces nocturnal adrenergic excess and directly improves sleep quality.
Fixed sleep/wake schedule. Screens off 1 hour before bed. Take propranolol last dose in the evening. Cool bedroom. Avoid caffeine (amplifies thyrotoxic tachycardia significantly). Avoid Z-drugs and benzodiazepines.
Chronic HPA activation from psychological stress disrupts regulatory T-cell immune tolerance and has been proposed as a trigger for Graves' onset and relapse. Psychological intervention may reduce relapse risk after completing antithyroid drug course.
NHS Talking Therapies referral for CBT if significant anxiety burden. Occupational health if work-related stress is affecting capacity for work. Mindfulness-based stress reduction has moderate evidence for quality of life improvement in autoimmune conditions.
Graves' ophthalmopathy is exacerbated by UV exposure and dry environments. Hyperthyroidism drives increased osteoclast activity — duration of uncontrolled disease determines degree of bone loss, making prompt treatment essential for skeletal protection.
Eye: wrap-around UV sunglasses, hypromellose drops, elevate head of bed by 15°. Avoid contact lenses during active GO. Bone: weight-bearing exercise once euthyroid; DEXA scan if prolonged disease; vitamin D and calcium supplementation.
Carbimazole 20–40mg OD + Propranolol 40mg TDS
- FT4 >40: start carbimazole 40mg. FT4 25–40: start 20–30mg. Review titration at 4–6 weeks
- Propranolol 40mg TDS for symptom control (tachycardia, tremor, anxiety) — wean once HR <80
- Give agranulocytosis warning in writing at this appointment — mandatory, document in notes
- Arrange FBC + LFTs before or at same visit as first prescription
Titration: reduce carbimazole once FT4 normalises. Maintenance 5–15mg/day
- Wean propranolol once HR <80 bpm at rest and tremor controlled
- Block-and-replace: add levothyroxine 50–100mcg once FT4 normal; keep carbimazole at 40mg
- Reinforce agranulocytosis warning — most cases within first 90 days
- Review driving, occupation, fertility plans — driving restriction lifted once euthyroid and HR controlled
Check TRAb titre before stopping medication — predicts remission probability
- Stop carbimazole (titration) or carbimazole + levothyroxine (B&R) simultaneously
- Recheck TFTs at 4–6 weeks, 3 months, and 6 months post-cessation
- TRAb negative at end of course = better remission probability (~70%)
- TRAb still elevated = >70% relapse risk → discuss definitive treatment proactively
Restart carbimazole as bridge + plan definitive treatment with endocrinology
- Radioiodine (¹³¹I): most cost-effective UK definitive option; outpatient; hypothyroidism expected 50–80% at 10 years; avoid if active GO, pregnancy, or breastfeeding
- Total thyroidectomy: fastest resolution; preferred for large goitre, malignancy suspicion, or severe GO; risk of hypoparathyroidism and RLN injury <2%
- Shared decision-making: patient preference, GO status, pregnancy plans, and occupation all influence choice
- T1 (<14 wks): PTU 200–400mg/day — carbimazole embryopathy risk in organogenesis
- T2/T3 (>14 wks): switch back to carbimazole — PTU hepatotoxicity risk increases in later pregnancy
- Lowest effective dose rule: aim FT4 upper-normal — fetal brain development needs adequate T4
- TRAb at 28–36 wks: titre >3× ULN at term = neonatal surveillance required
- Breastfeeding: carbimazole up to 20mg/day compatible; PTU also compatible
- Paediatric: carbimazole 0.5mg/kg/day; paediatric endocrinology essential
Select patient characteristics — see drug cards below for tailored recommendations
"If you develop a sore throat or a fever — even a mild one — while taking this tablet, stop it immediately and go straight to A&E the same day. Tell them you are on carbimazole. Do not wait to see if it gets better. This is rare but can become serious within 24 hours."
Agranulocytosis warning MUST be given verbally AND in writing at first prescription — document in notes. Failure to warn = clear Tasks deduction. Pre-warning the patient about expected weight regain = Relating to Others mark.
"This works very similarly to carbimazole and is slightly safer in the first three months of pregnancy. The same rules apply: any sore throat or fever — stop and go to A&E. And if you notice yellowing of your skin or eyes, stop immediately and come in or go to A&E that day."
Switching carbimazole → PTU in T1 pregnancy is a high-yield SCA moment. State the reason explicitly: "carbimazole carries a small risk to the developing baby in the first three months, so I'm using PTU instead." This scores Tasks domain. Switching back to carbimazole at T2 should also be stated and documented.
"This tablet won't treat the thyroid itself — it's more like a calming effect on your symptoms while the other medication does the real work. It should help your heart rate, tremor, and anxiety within 24–48 hours. We'll stop it gradually once your thyroid levels come down."
Critical SCA distinction: beta-blocker is NOT an antithyroid drug. It does not lower T4 or T3. Stating "propranolol treats the symptoms but not the underlying thyroid disease" explicitly = Global Skills mark. Prescribing beta-blocker alone without antithyroid drug = serious Tasks deduction.
"This is a one-time treatment — radioactive iodine targets the thyroid specifically. For 3 weeks afterwards, you'll need to avoid close contact with pregnant women and young children. We'll give you a full written guide. Most people do need a thyroid hormone replacement tablet afterwards, but that's straightforward to manage long-term."
High-yield SCA pearl: offering radioiodine to a patient with active Graves' ophthalmopathy without mentioning ophthalmology assessment + steroid cover = clear Tasks deduction. Always check GO status before definitive treatment discussion. Also: patient must know hypothyroidism is expected, not a treatment failure.
"This tablet replaces the hormone your thyroid would normally make. Take it first thing in the morning on an empty stomach, at least 30 minutes before food or other tablets — especially calcium or iron supplements, which interfere with absorption. Consistency is important: try to take it at the same time each day."
In B&R: levothyroxine is added to carbimazole — not prescribed independently. In SCA: stating the B&R rationale clearly ("we keep the carbimazole at the same dose and add the thyroid hormone tablet to prevent under-treatment") = Global Skills mark. Explaining post-RI hypothyroidism as expected, not a failure = Relating to Others mark.
"This solution is used for a short time only — usually just before an operation to reduce the blood supply to the thyroid and make surgery safer. It is not a long-term treatment. We'll give you clear instructions on how to take it."
Highest-yield SCA pearl for thyroid storm: the order is carbimazole FIRST → wait 1 hour → then Lugol's iodine. Reversing this order = potentially fatal. Demonstrating knowledge of the correct sequence explicitly in the consultation = clear Tasks domain mark and differentiates a pass from a borderline.
Driving & DVLA Notification
Uncontrolled tachycardia (>100 bpm) and significant tremor may impair safe vehicle operation — the patient has a legal duty to notify DVLA if these symptoms are present while driving. AF secondary to thyrotoxicosis requires formal DVLA notification regardless of symptom severity.
Once euthyroid state is confirmed and AF has resolved, DVLA will typically restore driving entitlement. Group 2 (HGV/PCV) licence holders must notify DVLA at diagnosis — stricter standards apply. Pilots, train drivers, and surgeons require specific occupational health clearance.
Occupational implications: fine motor tremor affects surgeons, dentists, and teachers. Document functional limitations specifically on MED3 to enable workplace adjustments rather than blanket sick leave.
"While your heart rate and thyroid levels are still elevated, I'd recommend not driving — this is a legal requirement, not just caution. Once we've got your levels stable in 4–6 weeks, we'll review this."Fertility, Pregnancy & Breastfeeding
Untreated hyperthyroidism impairs ovulation and is associated with first-trimester miscarriage, pre-eclampsia, and fetal growth restriction. Effective treatment substantially normalises pregnancy outcomes — fertility returns with euthyroid state.
TRAb crosses the placenta — maternal Graves' with high TRAb titre requires neonatal monitoring even when the mother is euthyroid post-treatment. Neonatal Graves' (tachycardia, goitre, poor feeding, weight loss in neonate) is transient but potentially severe if missed.
Both carbimazole (T2/T3) and PTU (T1) are compatible with breastfeeding at standard doses. Historical advice to avoid antithyroid drugs while breastfeeding is outdated — benefits strongly outweigh risks at recommended doses.
"Treating your thyroid disease properly actually improves your chances of a healthy pregnancy, not the other way round. The medication is safe — we just use a slightly different tablet in the first three months to be cautious."Employment & Sickness Absence
Cognitive effects of thyrotoxicosis — poor concentration, impaired short-term memory, anxiety — significantly affect performance in skilled roles. Teachers, doctors, lawyers, and managers may require temporary reduction in responsibilities during the period of uncontrolled disease.
Physical tremor and proximal myopathy affect manual work, fine motor tasks, and heavy lifting. Sickness absence may be needed for 4–12 weeks depending on severity. For MED3 fit notes: document specific functional limitations ("difficulty with sustained concentration and fine motor tasks") to enable reasonable adjustments rather than full absence.
Return to driving and operating machinery should be explicitly linked to achieving euthyroid state — advise patient that this is the primary target and approximate timeline for return to full function.
"I can provide a fit note today. Rather than signing you off completely, would it help to suggest some adjustments at work — like reduced class sizes or marking load — while we get your levels down? What would actually be most helpful for you?"Graves' Ophthalmopathy & Appearance
Visible eye changes — proptosis, lid retraction, periorbital oedema — significantly affect self-confidence and quality of life. Patients may avoid social events, photography, or client-facing work if visible changes are prominent. Diplopia affects reading, driving, and screen-based work.
Graves' ophthalmopathy can persist or worsen independently of thyroid biochemistry — even after achieving euthyroid state. Patients must be informed that eye changes may require separate, parallel treatment: selenium, IV steroids, orbital decompression, or lid surgery.
Smoking cessation is the single most important modifiable factor for ophthalmopathy — must be reinforced at every consultation. Refer to ophthalmology if any new or worsening eye symptoms regardless of thyroid control.
"The eye changes sometimes persist even after we treat the thyroid — but there's a lot the eye specialists can do specifically for the eyes. The key right now is protecting your corneas and making sure the inflammation doesn't worsen."Bone Health & Osteoporosis Risk
Sustained hyperthyroidism — even subclinical with persistently suppressed TSH — drives increased osteoclast activity and accelerated bone turnover. Prolonged uncontrolled thyrotoxicosis is associated with a 2–3× increased hip fracture risk in post-menopausal women and older men.
Prompt treatment of hyperthyroidism is the primary bone-protective intervention. Once euthyroid, bone mineral density partially recovers over 12–24 months but may not fully normalise if the hyperthyroid period was prolonged. DEXA scan is indicated after prolonged symptomatic disease (>6 months).
Vitamin D and calcium supplementation should be offered alongside antithyroid treatment. Bisphosphonate therapy for confirmed osteoporosis per NICE TA160. Weight-bearing exercise once euthyroid supports bone density recovery.
"An overactive thyroid does affect bone strength over time. Once we've treated the thyroid, I'd like to arrange a bone density scan to check on that. In the meantime, I'll start you on a vitamin D supplement."Post-Treatment Hypothyroidism
After radioiodine, 50–80% of patients develop hypothyroidism requiring lifelong levothyroxine. After total thyroidectomy, hypothyroidism is universal from the first post-operative day. Patients must understand this before consenting to definitive treatment — it is the expected outcome, not a complication.
Antithyroid drug-induced hypothyroidism (over-treatment) is a different entity — an iatrogenic complication of dose that requires carbimazole dose reduction. Distinguishing these two is important: one is a treatment success, the other is a prescribing adjustment.
Lifelong levothyroxine is a once-daily tablet with excellent quality of life when correctly dosed. Many patients find long-term stability on LT4 preferable to the uncertainty of repeated monitoring for relapse on antithyroid drugs.
"After radioiodine, many people do end up needing a thyroid hormone replacement tablet — most patients find that far easier to manage than the current treatment regime. It's worth going into this with that expectation."4–6 Weeks — First TFT Review
Check TFTs + FBC. Assess symptom response to carbimazole and propranolol. Titrate carbimazole downwards if FT4 is entering normal range — avoid over-treating. Wean propranolol if HR <80 bpm at rest. Reinforce agranulocytosis warning — most cases occur in the first 90 days. Confirm endocrinology referral was received and appointment scheduled.
3 Months — Symptom Consolidation Review
Review symptom control, driving status, work capacity, and eye signs. Ophthalmology review if GO symptoms or new proptosis. Review endocrinology letter and incorporate specialist advice. TFTs 4–6 weekly until stable for 3 consecutive results. Update fertility and pregnancy counselling — is patient trying to conceive? Adjust management accordingly.
9–12 Months — Ongoing Review
Step-down carbimazole dose if euthyroid for 3+ consecutive results. Begin proactive discussion about definitive treatment options — patient should be informed now about radioiodine versus thyroidectomy so they can consider preferences before the 18-month decision point. Recheck TRAb titre — elevated TRAb at this point predicts relapse. Smoking cessation update.
18–24 Months — Remission Trial
Stop antithyroid drug as planned — titration: stop carbimazole; block-and-replace: stop both simultaneously. Recheck TFTs at 4–6 weeks, 3 months, and 6 months. Normal TFTs across 3 consecutive results = confirmed remission. TSH suppresses again = relapse confirmed → restart carbimazole and refer to endocrinology for definitive treatment planning.
Annual — Post-Remission Surveillance
Annual TFTs for life — relapse can occur years after remission, and hypothyroidism can develop spontaneously even without treatment. DEXA scan if prolonged hyperthyroidism. Post-radioiodine: monitor for hypothyroidism annually with LFTs — start levothyroxine when TSH >10. Update smoking cessation status. Ophthalmology follow-up as needed for GO.
Memory rule
On carbimazole: TFTs every 4–6 weeks until stable, then every 3 months. FBC immediately if any sore throat or fever — stop the tablet that day and attend A&E. Do not wait for a scheduled test. Agranulocytosis onset is typically within the first 90 days and can progress to life-threatening sepsis within 24–48 hours if the drug is continued. Treatment target: FT4 12–22 pmol/L, TSH 0.5–2.5 mU/L. Over-treatment = hypothyroidism = failed consultation.
⚠ Three scenario-specific phrases — use these verbatim
Why safety-netting matters beyond clinical care
- Closing without asking the patient if they have any remaining questions
- Not giving the agranulocytosis warning at or before the close — the most important safety-net in this topic
- Failing to name the follow-up date or timeframe — "come back if anything changes" is not a named follow-up
- Not referencing the fertility concern in the closing plan despite it being raised during the consultation
- Using jargon in the final summary — "euthyroid" / "agranulocytosis" without explanation is not patient-centred
- Closing before the patient has confirmed they understand and agree with the plan — missing shared decision-making
- Working diagnosis shared in plain language — "overactive thyroid / Graves' disease" named
- ICE all three explored AND referenced in the management plan
- Specific drug choice stated with dose — carbimazole 40mg OD + propranolol 40mg TDS
- Agranulocytosis safety-net given — verbal + written, documented
- Named follow-up: "4–6 weeks" not "when you're ready"
- Patient's cancer fear directly and specifically addressed — not generic reassurance
- Fertility concern explicitly incorporated into the management plan
- Weight regain pre-warned as expected — normalises the side effect before it occurs
- Patient's agenda explicitly negotiated — "does this plan feel right for you?"
- Shared decision-making: options presented, patient's preference sought
- Empathy named at least once — "I know this has been a frightening few months"
Who you are
Sarah Chen, 34-year-old primary school teacher. Married with one child aged 3. Planning a second pregnancy in the next 6–12 months. Works in a high-pressure school with large class sizes. Mother had Graves' disease and took tablets for many years. Sarah has researched her symptoms extensively online and suspects she has either Graves' disease or thyroid cancer — she is frightened but trying to stay calm.
Hidden agenda
Sarah's primary hidden agenda is fear of thyroid cancer — she won't volunteer this unless asked, but if the doctor doesn't address it she will become increasingly anxious throughout the consultation. Her secondary hidden agenda is her fertility and pregnancy plans — she wants to know whether the medication is safe in pregnancy and whether treatment will affect her ability to conceive. She is also privately worried that she might need to take tablets for life, and is hoping for a "cure".
Symptoms if asked directly
- Palpitations constantly, especially at night — HR feels like it's racing
- Lost 8 kg over 3 months despite eating more than usual and feeling hungry constantly
- Sweating excessively; always feels too hot; colleagues have commented
- Fine tremor in her hands — noticed when marking; some parents have asked if she is okay
- Very irritable and anxious; snapping at her husband; sleeping badly
- Periods have become very light and irregular over the last 2 months
- Negative: no eye symptoms, no neck pain or swelling, no visual changes
Lifestyle + bonus details
- Non-smoker — this is important as it affects ophthalmopathy risk and radioiodine
- Alcohol: 1–2 units per week, socially only
- Not on any regular medication; tried ibuprofen for headaches but not regularly
- Stopped taking her multivitamin 2 weeks ago after reading they might contain iodine
- Bonus detail (only reveal if specifically asked about family history): her mother was on "thyroid tablets" for 18 months and then was cured — Sarah is hoping the same will happen to her
- Job stress: starting a new academic year with increased responsibilities; this started around the same time as symptoms
Resolution: Sarah will accept the plan and leave reassured if the candidate: (1) directly addresses the cancer fear with clinical reasoning — "this is not cancer, and here's why"; (2) explains carbimazole as a potential cure with honest remission statistics (~50% at 18 months) and discusses definitive treatment as a genuine curative option; (3) specifically addresses the pregnancy and fertility question — which drug is safe in T1 pregnancy (PTU), and that treatment improves rather than reduces fertility; and (4) names a specific follow-up date (4–6 weeks) and gives the agranulocytosis warning in writing. If the candidate does not address the cancer fear and fertility concern, Sarah's body language should become visibly more distressed and she should repeat her hidden agenda question more directly.
- Thyroid storm: fever >38.5°C + HR >140 + confusion (Burch-Wartofsky ≥45)
- Haemodynamically compromised thyrotoxic AF
- Thyrotoxic periodic paralysis (acute quadriparesis + hypokalaemia)
- Corneal exposure in Graves' ophthalmopathy
- ACS triggered by thyrotoxicosis
- New Graves' disease first presentation — start carbimazole today
- Hyperthyroidism in pregnancy — same-day obstetric liaison
- New stable thyrotoxic AF — anticoagulation decision
- Active Graves' ophthalmopathy (CAS ≥3) — urgent ophthalmology
- Agranulocytosis on carbimazole — STOP drug, same-day A&E
- Subclinical hyperthyroidism (TSH 0.1–0.4, normal FT4/FT3)
- Stable known Graves' on antithyroid drugs — TFT monitoring
- Post-radioiodine monitoring — watch for hypothyroidism
- Post-thyroidectomy LT4 dose optimisation
| Drug | Test | Timing | Stop threshold / Action |
|---|---|---|---|
| Carbimazole | TFTs + FBC | Every 4–6 weeks until stable | WBC <3.5 or neutrophils <1.5 → STOP immediately + A&E. FT4 <12 = over-treated → reduce dose. |
| Carbimazole (if unwell) | FBC urgent | Same day — any fever or sore throat | Any neutropenia = agranulocytosis until proven otherwise. Never rechallenge after confirmed agranulocytosis. |
| Propylthiouracil | TFTs + LFTs | Every 4–8 weeks | ALT >3× ULN or jaundice → STOP + urgent hepatology. Never rechallenge after PTU hepatitis. |
| Radioiodine | TFTs | 6wks, 3mo, 6mo, 12mo, annually | TSH >10 or symptomatic hypothyroidism → start LT4 25–50mcg. TSH still suppressed at 6mo → repeat dose consideration. |
| Levothyroxine | TFTs | 6–8 weeks after dose change; 6-monthly stable | TSH <0.1 = over-replaced → reduce dose. TSH >5 = under-replaced → increase by 25mcg. |